welcomes you to the new, improved website!Gosev and colleagues evaluated the baseline characteristics and outcomes in 156 patients from 12 centers who survived at least four years on left ventricular assist device (LVAD) support. Among this group of patients, mean survival was 7.1 years (95% CI 6.7 to 7.5 years). The average readmission rate was 1.1 ± 0.9 per patient-year, and the authors suggest that this low rate of complications could be responsible for the long survival seen in these patients.
You are here:
Long-Term Survival in Patients Receiving a Continuous-Flow Left Ventricular Assist Device
Source: The Annals of Thoracic Surgery
Source URL: https://doi.org/10.1016/j.athoracsur.2017.08.057
Keywords:
Author(s): Igor Gosev, Michael S. Kiernan, Peter Eckman, Behzad Soleimani, Ahmet Kilic, Nir Uriel, Johnatan D. Rich, Jason N. Katz, Jennifer Cowger, Brian Lima, Siobhan McGurk, Meredith A. Brisco-Bacik, Sanjin Lee, Susan M. Joseph, Chetan B. Patel, for the Evolving Mechanical Support Research Group (EMERG) Investigators
